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Catamenial Hemoptysis: A Case Report 
Paul S. Harkaway, MD,* and Michael S. Eichenhorn, MD* 
A young woman presented with recurrent hemoptysis temporally associated with menstruation. 
Catamenial hemoptysis, an extremely uncommon disorder, is usually caused by the presence of 
ectopic endometrial tissue within the lung. The use of progesterone suppressed menstruation and 
hemoptysis during four months of treatment. Chest x-ray was normal. (Henry Ford Hosp Med J 
1986:34:68-9) 
The differential diagnosis of hemoptysis is fairly limited. Frequently in the middle-aged and elderly it signals a se-
rious underlying process such as bronchogenic neoplasm. In the 
younger patient the differential diagnosis is even shorter but still 
can reflect serious pathology. No cause of hemoptysis can be 
said to be common in the young, but some more likely pos-
sibilities include: pneumonia or lung abscess, bronchiectasis, 
pulmonary infarction, bronchial adenoma, or A-V malforma-
tion. Catamenial hemoptysis is an unusual and still poorly un-
derstood disorder in which hemoptysis recurs in a cyclical fash-
ion in association with menstmation. Since it is so uncommon, 
little is known about its frequency, natural history, or response to 
therapy. 
Case Report 
A 21-year-old woman was refened for evaluation of hemoptysis. She 
was well until the previous evening when she began to recunently ex-
pectorate small quanfities of maroon-colored sputum. The patient de-
nied systemic symptoms, chest pain, or shortness of breath. She had no 
significant past medical history and was on no medications (including 
aspirin and oral contraceptives). The patient did describe a recent upper 
respiratory tract infection characterized by productive cough one week 
before presentation, but this had subsequently resolved. The patient 
was a cigarette smoker and had smoked one pack per day for the past 
two years. 
On further questioning the patient recalled that she had had a similar 
episode of hemoptysis four months before the cunent episode. She was 
seen in a local emergency room and told that she had a "bleeding vein in 
the back of the throat." Follow-up by an otolaryngologist disclosed no 
abnormality to explain the bleeding. 
Physical examination revealed a healthy woman. Vital signs were 
unremarkable as was the remainder of the physical exam including the 
pelvic examination. The chest x-ray was within normal limits (Figure) 
as were routine laboratory studies and a coagulation profile. The patient 
was treated with observation only, and the hemoptysis resolved spon-
taneously within the next two days. 
The patient retumed in four weeks with recunence ofthe same symp-
toms. It was recognized at that time that all three episodes of hemop-
tysis occurred during menstmation. Bronchoscopy was performed and 
demonstrated old blood in the trachea and bronchus intermedius. No 
endobronchial lesion was visualized. The patient had no symptoms of 
pelvic endometriosis and had no prior pregnancy, pelvic infection, or 
pelvic procedures. 
Hemoptysis recuned with each mensmial period until administration 
of medroxy progesterone acetate (20 mg twice a day) six weeks later 
The progesterone suppressed both menstmation and hemoptysis for 
four months but was discontinued because of poor patient tolerance. 
Menstruation and catamenial hemoptysis returned when the pro-
gesterone was discontinued. 
Discussion 
Catamenial hemoptysis is one of three ways in which the pres-
ence of endometrial tissue within the lung can manifest itself. It 
is an uncommon disorder with only a small number of cases hav-
ing been reported previously in the medical literature (1,2). Pul-
monary endometriosis generally presents as cyclic hemoptysis, 
pneumothorax, or as an abnormal density on chest x-ray. All of 
these are uncommon, however. The explanation for these un-
usual menstmal-associated pulmonary disorders is based upon 
speculation. Ectopic endometrial tissue has been proposed to 
find its way into the thorax by one of three mechanisms: hema-
togenous spread, coelomic metaplasia, or passage from the peri-
toneal to the pleural cavity across the diaphragm (3-6). Associ-
ated pelvic endometriosis is present in 30% of patients with 
thoracic involvement (1). 
Because of the small number of reported cases of catamenial 
hemoptysis, therapeutic experience has been purely anecdotal. 
Nonsurgical therapy has consisted of hormonal manipulation to 
suppress menstmation with progesterone or danazol (1,2,7,8). 
Cases have been described in which hemoptysis resolved per-
manently after several months of hormonal therapy, particularly 
with danazol (1,7,8). Pulmonary resection has been effective in 
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Figure—Chest x-ray within normal limits. 
two reported patients in whom a nodule composed of tissue his-
tologically resembling endometrial tissue was identified and re-
sected (1). One case report has suggested that recunent pulmo-
nary hemonhage secondary to catamenial hemoptysis may 
predispose to the development of bronchiectasis (9). 
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